The Agenda

San Francisco, CA, 13 - 14 March 2018

Schedule

Create your personal agenda –check the favourite icon

Mar 1308:20
Conference pass

First DNA Sequencing in Space a Game Changer

Keynotes
  • What is the purpose of sequencing in space
  • Opening a whole new world of scientific and medical possibilities
  • What are the merits and possible experiments that can be conducted as a result of this?
Mar 1309:00
Conference pass

Bringing big data and genomics to unlock cures

Keynotes
  • What is the current state of the field and how have new techniques in data analytics allowed us to probe deeper into data sets to gain understanding of rare disease morphologies?
  • How do we connect millions of disease specific data points using novel statistical machine learning techniques to develop new therapies?
  • The time is now - how does UCSF leverage the power of supercomputing infrastructure, once reserved for astrophysicists, to develop new pathways to cures?
Mar 1309:20
Conference pass

Where does emerging technology such as AI, precision medicine and next generation diagnostics fit into a health system- What is the value? Where is the evidence? How do you persuade us to implement?

Keynotes
  • Is the clinic ready for the influx of new precision medicines?
  • What are CIOs at large healthcare systems looking for to drive precision medicine into the clinic?
  • What value has been generated to health systems through precision medicine? Are we focusing on the right priorities?
Vipul Kashyap, Chief Information Architect, Northwell Health
Adam Berger, Senior Staff Fellow of Personalized Medicine, Food and Drug Administration
Benson Hsu, Physician, Sanford Health
James Dzierzanowski, Executive Director, Kaiser Permanente
Mar 1310:00
Conference pass

PLATINUM SPONSORSHIP AVAILABLE

Keynotes
PLATINUM SPONSORSHIP AVAILABLE
Do you have a solution you would like to share with our audience?
Contact Michael Shackil now on: michael.shackil@terrapinn.com or call at +1 646.619.1809
Mar 1311:20
Conference pass

Developing “DAVE”: a simple way to visualize large datasets in the battle against cancer

GENOMICS & HEALTH
  • How new tools and platforms developed by the NCI are changing the paradigm of data accessibility across the country
  • How these tools allow us to keep up with the exponential worldwide growth of genomic datasets
  • How to carry out complex analysis at the data source whilst allowing the user to explore the data and download the desired facets
Mar 1311:20
Conference pass

Using different whole genome sequencing platforms to characterize cancer genomes and their clinical impact

PRECISION MEDICINE
  • How do we balance the equation of Speed: Depth: Cost across genomic sequencing options
  • Covering Illumina and high throughput whole genome sequencing including mate-pair sequencing
  • What is the impact of BGI’s proposed $100 whole genome on the clinician and what is the value add to preemptive care?
David Smith, Professor of Laboratory Medicine And Pathology, Mayo Clinic
Mar 1311:20
Conference pass

Rethinking predictive modelling in the age of AI

ARTIFICIAL INTELLIGENCE
  • How Numerate’s platform drives programs by following signals and unlocking low through-put / high content biology
  • Applying similar modeling techniques with publicly available data in order to successfully model a vast number of sources of preclinical attrition (ADME and tox)
  • Why pharma and health systems need to start sharing data to guarantee the success of predictive modelling
Mar 1311:40
Conference pass

New analytical tools for OMICS How to get the best out of your data!

GENOMICS & HEALTH
  • Tackling the new emerging field of integrating disparate omic data from genomics, proteomics andglycomics
  • Identifying the technical and biological barriers to omic integration, with solutions to build a consensus towards data integration in bioscience and better defined phenotypes
  • What is being done to facilitate the integration effort in an effective manner?
John Weinstein, Professor and Chairman for Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center
Mar 1311:40
Conference pass

Integrating gene panels and EMR records to develop treatment pathways and cancer cure frameworks on large scales

PRECISION MEDICINE
  • What impacts will the expansion of the Swedish Precision medicine program have on healthcare across the system?
  • Implementing new technologies - How we are implementing the roadmap for the delivery of next generation precision medicine into the Providence Health System?
  • What evidence is there for universal genetic testing of cancer patients and will it bring the expected value?
Mar 1312:00
Conference pass

Accelerating clinical development with AI driven approaches to patient stratification

GENOMICS & HEALTH
  • "One size fits all" has been the answer from the pharma industry to patients for decades
  • In the era of value-based care, the reimbursement model dictates a new reality of pay for performance
  • There is an opportunity to utilize patient molecular and digital data for pre-treatment stratification in clinical development
  • The Interrogative Biology(r) platform is designed for discovery of AI-driven multi-omic companion diagnostic markers early in clinical development with subsequent validation in follow-on trials
Mar 1312:00
Conference pass

Multimodel data analysis for single cell multiuse data for immunotherapy

PRECISION MEDICINE
  • Predictive biomarkers for ovarian and liver cancer developed through novel self-leaning algorithms to provide actionable cures
  • How to translate an equation into a cure in less than a year using new algorithms
  • Predicting response to blockade to specific immune checkpoint genes
  • Multimodel data analysis for biomarker discovery
Gordon Okimoto, Co-Director, Biostatistics and Informatics, University of Hawaii Cancer Center
Mar 1312:00
Conference pass

Extracting precise biodata through the power of text mining

ARTIFICIAL INTELLIGENCE
  • Empowering high-value knowledge discovery and decision support
  • Improving risk stratification through the characterization of patient populations based on social determinant data
  • Supporting clinical document improvement through NLP
David Milward, CTO, Linguamatics
Mar 1312:20
Conference pass

INTERACTIVE E ROUNDTABLES

Keynotes
1) Integrating EMR -Integration of electronic medical records with a biomedical knowledge network to predict medical outcomes
Chair: Sergio Baranzini, Professor UCSF

2) Collaboration -How to enable researchers to use data and collaborate easier?
Chair: Christopher Riley, Research Administration Manager, The Institute for Precision Cardiovascular Medicine

3) Quantum Computing -Where are we and what we are doing?
Chair: Handol Kim, General Manager, Quadrant Machine Learning Business Unit, D-Wave Systems, Inc

4) CLSA California -Partnering and driving a hot bed of translational medicine in California
Chair: Sara Radcliff, President and Chief Executive Officer, California Life Sciences Association

5) Electronic Consent - How to develop an electronic e-trial strategy effectively?
Chair: Megan Doerr, Principal Scientist, Sage Bionetworks
Sarah Meeder, Research Compliance Specialist, CUNY

6)Challenges in Surveillance and Detection:Finding the Needle in the Haystack

Chair: Westyn Branch-Elliman, Instructor in Medicine, Harvard Medical School

7) Drug Discovery - Expediting the drug development through genomics, structural and cultural changes
Chair: Nadeem Sarwar, President, AiM Institute, Eisai

8) Big Data and the CNS - using big data datasets and approaches in the development of medicines for CNS indications including NDDs and pain/migraine disorders
Chair: Michael Burczynski, Senior Director and Head of Translational Biomarker Research, Early Stage Development, Teva

9) Stem Cells & Rare Disseises - How to develop an infrastructure in which researchers can be connected with patients and tools to develop therapies

10) Text mining and Image Recognition - Developing new tools
Chair: Karim Galil, CEO, Mendel Health

11) Scientific Software- Enabling research at Verily
Chair: Mauricio Carneiro, Head of Scientific Software, Verily (Google Life Sciences)

12) Standards in Genetic Testing – Setting the benchmark in quality data sets
Chair: Robert Burton, Founder and CEO, Center for Genomic Interpretation

13)DTC and recreational genetic testing- Understanding the issues
Chair: Jeanette Mccarthy, Adjunct Associate Professor, Duke University


Big Data and the CNS - using big data datasets and approaches in the development of medicines for CNS indications including NDDs and pain/migraine disorders
CLSA California: Partnering and driving a hot bed of translational medicine in California
Sara Radcliffe, President and Chief Executive Officer, California Life Science Association
Collaboration: How to enable researchers to use data and collaborate easier?
Drug Discovery - Expediting the drug development through genomics, structural and cultural changes
Nadeem Sarwar, President AiM Institute, Eisai
DTC and recreational genetic testing- Understanding the issues
Jeanette Mccarthy, Adjunct Associate Professor, Duke University
Electronic Consent - How to develop an electronic e-trial strategy effectively?
Sarah Meeder, Research Compliance Specialist, Maimonides Medical Center Inc
Megan Doerr, Principal Scientist, Sage BioNetworks
Finding the Needle in the Haystack: Challenges in Surveillance and Detection
Westyn Branch-Elliman, Instructor in Medicine, Harvard Medical School
Integrating EMR: Integration of electronic medical records with a biomedical knowledge network to predict medical outcomes
Sergio Baranzini, Professor, UCSF
Quantum Computing: Where are we and what we are doing?
Handol Kim, Sr. Director, Quadrant Machine Learning BU, D-Wave Systems
Scientific Software- Enabling research at Verily
Mauricio Carneiro, Head of Scientific Software, Verily (Google Life Sciences)
Standards in genetic testing – Setting the benchmark in quality data sets
Stem cells & Rate Disseises - How to develop an infrastructure in which researchers can be connected with patients and tools to develop therapies
Text mining and image recognition - Developing new tools
Mar 1313:00
Conference pass

NETWORKING LUNCH

Keynotes
Mar 1314:20
Conference pass

Understanding the new blockchain ecosystem - empowering research and data democratization in a secure manner

GENOMICS & HEALTH
  • Improve drug traceability between drug manufacturers, wholesalers, pharmacists and patients through tracking and verification of secure product information
  • Improving authentication of health records and protocols on record sharing
  • Empowering clinical trials where altering or modifying data from clinical trials fraudulently can be eradicated
  • Precision medicine - where patients, researchers and providers can collaborate to develop individualised care
Verner De Biasi, Head Emerging Platforms, GSK
Mar 1314:20
Conference pass

Risk management for precision medicine and big bioda

PRECISION MEDICINE
  • How to implement a risk mitigation process amongst a complex healthcare system
  • Essential parts of the risk management program and case studies on they were implemented at Lifespan
  • What are the advantages of systematic frameworks to identifying, assessing, and addressing risks in the implementation of precision medicine?
James Barbeau, Director of Laboratory Medicine, Lifespan/Brown University
Mar 1314:20
Conference pass

A computational approach for identifying synergistic drug combinations- fuelling a new generation of drug combinations to treat cancers

ARTIFICIAL INTELLIGENCE
  • Identification of the right combinations through trial and error, a labor and resource intensive process whose scale quickly escalates as more drugs can be combined
  • Engaging in the development of a broad computational approach for predicting synergistic combinations using easily obtainable single drug efficacy.
  • How does this allow you to forego a detailed mechanistic understanding of drug function, and limited drug combination testing?
  • Why is this method impactful for identification of drug synergy to drive new effective cancer cures into the clinic?
Olivier Elemento, Director, Laboratory of Cancer Systems Biology, Englander Institute for Precision Medicine Institute for Computational Biomed, Cornell University
Mar 1314:40
Conference pass

Blockchain: how to make it work for emerging and less-developed healthcare systems

GENOMICS & HEALTH
  • Exploring options using blockchain to achieve better health data storage and applications
  • Discussing clinical data access, exchange, interoperability, privacy issues and regulatory concerns
  • How applications for pharma focus on aging and longevity research, which could enable Africa to make more original contributions to healthcare
  • How optimizing processes for emerging and less-developed healthcare systems like in Africa could be helpful in the acceleration of progress for more developed healthcare systems
Mar 1314:40
Conference pass

California’s Initiative to advance Precision Medicine from the bench to the bedside –

PRECISION MEDICINE
  • Hear how the Governor of California’s interest and leadership in the field led to statewide collaborative models to realize the potential of precision medicine
  • How the state established multi-sector collaborative teams to advance efforts in precision medicine
  • Examples from the eight demonstration projects that range from heart disease to pediatric cancer
Elizabeth Baca, Senior Health Advisor Governor's Office of Planning and Research, State of Califonia Governor's Office of Planning and Research
Mar 1314:40
Conference pass

Novel CNS drug targets in the regulome identified by deep learning

ARTIFICIAL INTELLIGENCE
  • How to use domain expert knowledge-driven deep learning of pharmaco-phenomic datasets to yield abundant human CNS drug targets
  • Moving beyond the known "reader, writer and eraser" proteins: using computational methodologies to identify more selective candidates
  • Utilizing a spatial, longitudinal and biomechanical dynamical analysis of the output to reveal previously unknown network-based drug targets
Mar 1315:00
Conference pass

Computational identification of isoform switch and alternative splicing events in ZSF1 fa/faCP rats, a model of human type 2 diabetes: How new isoform technologies could transform research and healthc

GENOMICS & HEALTH
  • Identification of predictive biomarkers of disease progression using isoform level sequencing- what are the potential implications for the clinic?
  • Why are we not moving to isoform level resolution that could provide us with real biological insights?
  • With a greater understanding of isoform switching we can remove the chance of false signals for cancer states - how significant is isoform level sequencing in removing signal noise?
Shanrong Zhao, Director, Computational Biology and Bioinformatics,Worldwide R&D, Pfizer
Mar 1315:00
Conference pass

Partnering for Scientific Leadership

PRECISION MEDICINE
  • Astrazeneca Overview, strategy and areas of focus
  • Achieving Scientific Leadership
  • Precision Medicine at Astrazeneca
  • Open Innovation Partnerships & Initiatives
Nicole St Jean, Director, Precision Medicine, AstraZeneca LP
Mar 1315:00
Conference pass

Sponsored by Tellic LLC

ARTIFICIAL INTELLIGENCE
Mar 1315:20
Conference pass

Systems biology approaches to determine the cell-specific gene regulatory potential of genetic associations in complex diseases

GENOMICS & HEALTH
  • Genetic association studies identify risk DNA variants but fall short of providing a biological context
  • How UCSFe integrated GWAS data with regulatory information from ENCODE and REP and built cell-specific biological risk networks
  • How UCSF employed this approach to create individualized cell-specific risk networks to characterize risk in more than 2000 patients
Sergio Baranzini, Professor, UCSF
Mar 1315:20
Conference pass

Augmenting Drug Discovery with Artificial Intelligence at Massive Scale

PRECISION MEDICINE
  • Bringing substantial improvements to the efficiency of discovery and development efforts through the expansion and acceleration of traditional approaches
  • How Recursion views the use of AI in discovery and development – from strategies to accelerate discovery and imaged-based phenotypic screening platforms
  • Overviews of internal successes in rare disease, immunology, and immuno-oncology alongside partnerships with large pharmaceutical companies including Sanofi and Takeda
  • Recursion’s 5-7 year vision to leverage technology and massive proprietary datasets to build a map of human cellular biology
Chris Gibson, Chief Executive Officer and Co Founder, Recursion Pharmaceuticals
Mar 1315:20
Conference pass

Developing new drug targets for aging through novel insilico methodologies

PRECISION MEDICINE
  • Aging has become a major risk factor for many diseases including cancer, diabetes, heart disease and dementia
  • Defining new tools for the applications of aging research and information technology
  • Empowering new business models, regulation, comprehensive and integrated set of aging biomarkers
  • New engagements with large pharmaceutical companies and investors to fully drive the field forwards
Alex Zhavoronkov, CEO, Insilico Medicine, Inc
Mar 1315:40
Conference pass

MyGeneRank: A digital platform for Next-Generation genetic studies

GENOMICS & HEALTH
  • Building a fully digital ecosystem for community-based participatory genetics research: what are the societal benefits and how could this inspire a new generation of preventive health technology platforms?
  • Linking genetic + digital health data for health and behavioral insights and understanding how lifestyle factors affect non-communicable diseases such as CHD
  • Implementing at-home diagnostics for those at high-risk of non-communicable disease through combined genetic & health data to enable doctors to prescribe and monitor patient centric personalized apps in realtime
Mar 1315:40
Conference pass

Molecular signatures of human mortality: biomarkers and therapies

PRECISION MEDICINE
  • Accelerating drug testing by developing molecular signatures of mortality
  • Attaining the best signatures by deeply phenotyping large human cohorts
  • High-throughput omics data, coupled with innovative machine learning, is revealing new biomarkers and drug targets
Mar 1315:40
Conference pass

Fuelling R&D productivity & innovation with AI

ARTIFICIAL INTELLIGENCE
  • How Pfizer uses advanced analytics and AI to drive forwards pharmaceutical development
  • Use cases ranging from business process engineering and automation to insights from healthcare data and genomics
  • What are the key obstacles to AI implementation?
Morten Sogaard, Vice President and Head, Genome Sciences & Technologies, Worldwide R&D, Pfizer
Mar 1316:00
Conference pass

Combining artificial intelligence and collective intelligence to democratize bioinformatics

GENOMICS & HEALTH
  • Designing the future of bioinformatics thanks to the OMICtools community
  • How to find the right pipeline of tools thanks to AI-based decision-making solutions?
  • Making bioinformatics accessible without the need for advanced IT skills
Arnaud Desfeux, CEO, OMICtools
Mar 1316:00
Conference pass

Viome – our moonshot of creating a world where chronic illness can truly be a matter of choice

PRECISION MEDICINE
  • Why human microbiome is influential if not outright responsible for most chronic diseases
  • Hear about the technology that enables us to analyze microbial ecosystems, biochemical activities and immune system responses with AI and modulate these activities with food and nutrition
  • How exponential technologies are now making it possible for consumers to get insights into their bodies and act on them to prevent and reverse chronic conditions
Helen Messier, Chief Medical Officer, Viome
Mar 1316:00
Conference pass

Programmable biology: empowering the Pocketome

ARTIFICIAL INTELLIGENCE
  • The design and engineering of molecular, cellular and population-based computation
  • Domain-specific languages for the specification of biological computation
  • Theories and applications of biological computation
Riccardo Sabatini, Co-Founder, Chief Data Officer, Orionis Biosciences
Mar 1316:20
Conference pass

Merck Presentation- Details Pending

GENOMICS & HEALTH
Caroline Fox, Vice President and Head of Genetics and Pharmacogenomics, MSD
Mar 1316:20
Conference pass

SPONSORSHIP AVAILABLE

PRECISION MEDICINE
Do you have a solution you would like to share with our audience?
Contact Michael Shackil now on: michael.shackil@terrapinn.com or call at +1 646.619.1809
Mar 1316:20
Conference pass

LUNIT TITLE TBC

ARTIFICIAL INTELLIGENCE
Mar 1317:10
Conference pass

PLATINUM SPONSOR

Keynotes
To speak and sponsor please contact Michael Shackil
Michael.Shackil@terrapinn.com
Mar 1317:30
Conference pass

Establishing modern enterprise architecture in a Pharmaceutical R&D division

Keynotes
  • Scaling and enabling innovation
  • How to enable speed and agility alongside increasing business and IT efficiency and effectively
  • Case study: How implementation efforts within IT infrastructure empower data democratization
Vipul Kashyap, Chief Information Architect, Northwell Health
Martin Sjoholm, Senior Enterprise Architect, Bayer HealthCare
Maria Helena van de Pol, Global Area Head, Research IT, Roche
Sunil Erraballi, Information Technology & Finance, Selten Pharma Inc
Mar 1318:00
Conference pass

AI - The Ethical Debate

Keynotes
  • With unprecedented data sharing via the cloud we have been provided with vast data lakes at our fingertips.
  • Harnessing meaning from this data is possible through AI.
  • However, as AI advances we are unable to always disseminate why or how it has deduced meaning from the data.
  • With garbage in garbage out does AI become biased?
James Dzierzanowski, Executive Director, Kaiser Permanente
Greg Corrado, Principal Scientist, Director of Augmented Intelligence Research, Google Brain Team Co-founder, Google Brain/Verily
John Havens, Executive Director, Global Initiative on Ethics of Autonomous and Intelligent Systems
Mar 1318:30
Conference pass

Networking Cocktail Reception

Keynotes
YOUNG TALENT IN AI AWARD 2018
Proposed by our partners in the field, this award will be presented to the most innovative and impressive example of AI research in BioData

Create your personal agenda –check the favourite icon

Mar 1408:45
Conference pass

Producers opening remarks

Keynotes
Edward Glanville, Project Director, Terrapinn USA
Mar 1408:50
Conference pass

NASA GeneLab Project: using multi-omics to understand how space impacts life

Keynotes
  • Inferring knowledge from diverse datasets using new NASA tools
  • GeneLab data: factors influencing life in the space shuttle and the ISS including radiation and microgravity and what this means for humans back on earth
  • How to engage a larger community via higher order data and analysis working group
  • How to transfer the power of NASA based technologies into healthcare through collaborative efforts like NCI and NASA
Mar 1409:00
Conference pass

Large Scale Deep Neural Networks to empower diagnostics and drug development: learnfrom the company at the bleeding edge of AI

Keynotes
  • Developing Google’s largest deep scale network – How do 16,000 computers studying 10 million images of cats help towards developing early diagnostics for disease?
  • Understand the power of deep neural networks and develop new targets and implement powerful deep learning networks to empower drug discovery
  • Open source tensor flow platforms -taking your drug development full steam through the world’s most powerful open AI chip
Greg Corrado, Principal Scientist, Director of Augmented Intelligence Research, Google Brain Team Co-founder, Google Brain/Verily
Mar 1409:40
Conference pass

Developing the Inova Precision Medicine Roadmap: Convergence of implementation science, precision medicine, and the learning healthcare system

Keynotes
  • What are the challenges faced when implementing a system wide precision medicine platform across a healthcare system ?
  • Developing a harmonized road map for the implementation of precision medicine- Real world case studies on implementation of precision medicine at Inova
  • What were the financial implications and how can the model benefit your precision medicine implementation strategy?
  • Collaborations and partnerships with vendors to make the process work How to make it a success story through developing early stage frameworks?
Mar 1410:00
Conference pass

Accelerating Advances in Cancer Therapy through RWD

Keynotes
Jacqueline Law, Vice President, Global Head, PHC Data Science, Personalized Healthcare, Product Development, Genentech
Mar 1411:00
Conference pass

How do you use metadata to unlock the true potential of health data?

GENOMICS & HEALTH
  • Taming the stream of bytes- why disseminating data is not enough- How tagging and curating maximizes the capability of your data
  • New directions in data curation- how new strategies have been developed out of ICPSR to allow for easy accessibility and retrieval of data
  • How metadata enhances discovery, use, and preservation- maintenance of data is key – do you do enough?
Amy Pienta, Associate Research Scientist, ICPSR
Mar 1411:00
Conference pass

Collaborations with Industry to accelerate rare disease discoveries in the fastest way possible

PRECISION MEDICINE
  • How to structure relationships to protect the interests of all parties when dealing with rare diseases
  • What are the required infrastructure to make partnerships work?
  • Understanding the importance of phenotyping, transparency, and patient engagement
Mar 1411:00
Conference pass

Brain Genomics and machine learning- How to get a deep dive into the world of brain genomics?

ARTIFICIAL INTELLIGENCE
  • Review of the history and taxonomy of machine learning and artificial intelligence
  • Introducing deep learning- How is its power increasing and how will it will change the face of healthcare?
  • Concrete applications of AI to life sciences problems (calling SNP and indel variants in next-generation sequencing data & detection of diabetic retinopathy from fundus images of the eye)
Ryan Poplin, Machine learning technical lead, Google Inc
Mar 1411:20
Conference pass

IT infrastructure to speed the delivery of Precision Medicine into the clinic

GENOMICS & HEALTH
  • How to develop an efficient network architecture to empower research across your institution
  • New requirements for the big data era are chancing - how are you preparing
  • Customized working environments:using multi scenario prioritization to put the dollars back into the researcher’s pocket and save computing power
Mar 1411:20
Conference pass

Biobanks - propelling precision medicine into the clinic in the fastest way possible

PRECISION MEDICINE
  • Hear how Kaiser Permanente has implemented precision medicine within its existing nationwide healthcare system
  • How biobanks with research ready biospecimens and associated EMR data pave the way for the development of further physical tied to EMR databases
  • How digitalization of biobanks allows efficient access to specimens empowering researchers to get what they need in the fastest and efficient way possible
Mar 1411:20
Conference pass

Developing trials of the future

ARTIFICIAL INTELLIGENCE
  • How wearables are changing patient centeredness and compliance for clinical trials
  • Digital Biomarkers and Digital Therapeutics: See how digitalization leads to better efficiency and insights
  • Developing large wearables trials - the lessons learned from building arrhythmia data sets through wearables
Mintu Turakhia, Executive Director, Center for Digital Health, Stanford University, Stanford University
Mar 1411:40
Conference pass

Developing an ecosystem in which EHR and genomic data can flow freely

GENOMICS & HEALTH
  • Elements of MVP (Million Veterans Program): the direction for the future, and strategies to transform genomic efforts into the clinic
  • Building one of the world's largest medical databases by safely collecting blood samples and health information from one million Veteran volunteers
  • How to manipulate one of the largest genomic data sets in the world
  • Future use of MVP data to enhance the health of veterans
Ronald Przygodzki, Director, Genomic Medicine Implementation, U.S. Department of Veterans Affairs
Mar 1411:40
Conference pass

Rare diseases and precision medicine

PRECISION MEDICINE
  • Accelerating development of novel therapeutics through the transition of genomic data into the AI based drug development
  • Driving patient centricity through big data to drive cures to the patient in the fastest way possible
  • Intercalating genomics and EHR records in an efficient and secure manner to drive forwards trail recruitment
Mathew Pletcher, Head of Rare Disease Discovery, Roche
Mar 1411:40
Conference pass

Computational Drug Discovery using Artificial Intelligence

ARTIFICIAL INTELLIGENCE
  • Learn novel Deep Learning for design of new molecules
  • Benefits of AI for increasingly more accurate property predictions
  • Combining multi-modal data streams into predictive modeling workflow
  • ADME/Tox and off-target property optimization with AI methods
Mar 1412:00
Conference pass
Mar 1412:00
Conference pass

SPONSORSHIP AVAILABLE

PRECISION MEDICINE
Do you have a solution you would like to share with our audience?
Contact Michael Shackil now on: michael.shackil@terrapinn.com or call at +1 646.619.1809
Mar 1412:00
Conference pass

Novel Ensemble Computational Intelligence Strategies for Predictive Modeling and Deep Learning in the Biosciences

ARTIFICIAL INTELLIGENCE
  • How Artificial Intelligence is the single most transformative technology in human history
  • Defining how advancements in personalized medicine depend upon significantly furthering our current understanding of how genetic variation and somatic mutation regulate aberrant gene activity and subsequent disease biology, including the myriad of dysregulated molecular mechanisms of cancer
  • Building advanced deepCODE feature engineering strategies to quantitatively integrate multiple types of high-throughput omics data with patient clinical information.
  • How novel approaches improve the performance of statistical-learning methods and subsequent identification of causal genes and molecular signalling networks more highly predictive of disease etiology and patient survival
Tom Chittenden, Vice President, Statistical Sciences and Founding Director, Advanced Artificial Intelligence Research Laboratory, WuXi NextCODE
Mar 1413:40
Conference pass

"Quantum Technology and QuantumBio" – an analysis

GENOMICS & HEALTH
  • Hear the background and history of quantum and how it relates to the future of medicine
  • Understand the potential and the benefits of quantum tech in healthcare?
  • Who are the Discuss key research teams, vendors, technologies and the most forward-thinking research?
Karen Hurst, Futurist & Lead Architect in Technology / R&D, Kaiser Permanente
Mar 1413:40
Conference pass

Scaling real world collective intelligence

PRECISION MEDICINE
  • Prediction: Gaining insights into new platforms to drive a new paradigm of AI
  • Precision: Develop a new understanding of the precision machine learning techniques that empower precision.
  • Prevention: Stabilizing patients before symptomatic onsets
Thomas Clozel, co-founder, OWKIN
Mar 1413:40
Conference pass

Developing translational medicine through the three main pillars: benchside, bedside and community

ARTIFICIAL INTELLIGENCE
  • How to enable the transition of knowledge between the three pillars of translation
  • Utilizing digital technologies to empower collaboration to accelerate research
  • Understanding the educational road map and processes across the translational field
Moderator: Christina Waters, President & Chief Executive Officer, R.A.R.E. Science
Ashley Winslow, Senior Director of Translational Research, University of Pennsylvania
Dawn Ireland, President, CDH International
Mar 1414:00
Conference pass

Scalable quantum simulation of molecular energies: Towards an exact (quantum) description of chemistry

GENOMICS & HEALTH
  • Understanding the advantages of the discipline in the acceleration of research
  • How molecular energy functions can be be defined by quantum computing faster than by classical models
  • Understand the advantages of quantum for your drug development process and assess the impact on computing power
Mar 1414:00
Conference pass

The genetics of drug efficacy: opportunities and challenges

PRECISION MEDICINE
  • How efficacy has become the most common cause of attrition in late-phase drug development
  • Driving the application of efficacy pharmacogenetics into drug discovery and development across industry
  • Defining the value of routine, early and cumulative screening for genetic predictors of efficacy, as an integrated component of clinical trial analysis
Matt Nelson, Head, Genetics, GSK
Mar 1414:00
Conference pass

Tools to accelerate testing of new Parkinson's treatments by assisting in trial design and subject stratification

ARTIFICIAL INTELLIGENCE
  • Identifying early clinical markers of rate of progression – how to benefit clinical care and testing of new therapies
  • Characterizing subgroups based on clinical symptoms – how to allow trial sponsors to test new therapies
  • Developing new avenues for investigations – how pathophysiology can be targeted in a more efficient way through AI
Duygu Tosun-Turgut, Assistant Professor and Co-Director of the Center for Imaging of Neurodegenerative Diseases (CIND), San Francisco Veterans Affairs Medical Center
Mar 1414:20
Conference pass

Understanding the power of Quantum Computing in Drug Discovery

GENOMICS & HEALTH
  • By leveraging the properties of quantum physics in computing, quantum computers are being designed to be millions of times faster than classical computing for solving complex business problems
  • Quantum computing has the potential to transform traditional R&D drug discovery processes, improve speed and productivity alongside significantly reducing costs and accelerating access to new therapies for patients
  • Unveiling a first-of-its-kind quantum-enabled molecular comparison application that could significantly improve advanced molecular design to speed up drug discovery for complex neurological conditions
Mar 1414:20
Conference pass

Intermountain Precision Genomics for Everyday Patients

PRECISION MEDICINE
  • Developing efficient and rapid diagnostic processes using WGS and gene panels
  • Comparing WGS and gene panels in areas such as cost vs time implications and he future of the technology
  • Navigating care pathways with the guidance of genomics data to provide economic value to institutions
Pravin Mishra, Director, Precision Genomics Core Laboratory & R&D, Intermountain Healthcare
Mar 1414:20
Conference pass

What would patients say if you asked them?

ARTIFICIAL INTELLIGENCE
  • How patient experience is changing the way pharma thinks about drug development
  • What patients can share with pharma: now and in the future
  • What are the key lessons learnt from the frontline of patient engagement?
Julie Walters, Founder, Raremark
Mar 1414:40
Conference pass

SPONSORSHIP AVAILABLE

GENOMICS & HEALTH
Do you have a solution you would like to share with our audience?
Contact Michael Shackil now on: michael.shackil@terrapinn.com or call at +1 646.619.1809
Mar 1414:40
Conference pass

SPONSORSHIP AVAILABLE

PRECISION MEDICINE
Do you have a solution you would like to share with our audience?
Contact Michael Shackil now on: michael.shackil@terrapinn.com or call at +1 646.619.1809
Mar 1414:40
Conference pass

SPONSORSHIP AVAILABLE

ARTIFICIAL INTELLIGENCE
Do you have a solution you would like to share with our audience?
Contact Michael Shackil now on: michael.shackil@terrapinn.com or call at +1 646.619.1809
Mar 1415:40
Conference pass

DATA DEMOCRATIZATION AND USIBILITY

GENOMICS & HEALTH
  • Solving the dilemma of data democratization: current methodologies for freeing data from stasis
  • Dollars vs Altruism: Utilizing novel technologies such as block chain to provide a financial ecosystem to allow for data sharing
  • How to leverage usability of phenotypic and genotypic data through computational efforts to create a graphical database
Noel Burtt, Associate Director of Operations, Diabetes Research, Broad Institute of MIT & Harvard
Andreas Kogelnik, President and Founder, Open Medicine Institute
Elia Stupka, Senior Director, Dana Farber Cancer Institute
Matthew Trunnell, Vice President & CIO, Fred Hutchinson Cancer Research Center
Scott Brandon, Executive Director, OpenMed Access
Mar 1415:40
Conference pass

PRECISION MEDICINE 101

PRECISION MEDICINE
  • An overview of the clinical applications of genomic medicine, skills to evaluate clinical validity and utility of new tests, and the associated ethical and social issues inherent to genomics
  • Conceptual and practical information about real-world applications of genomics
Westyn Branch-Elliman, Instructor in Medicine, Harvard Medical School
Mar 1415:40
Conference pass

ROUND TABLES

ARTIFICIAL INTELLIGENCE
Round Table 1
Augmenting Human Intelligence through AI
Prasun Mishra, Founder and CEO Agility Pharmaceuticals, CEO, American Association for Precision Medicine

Round Table 2
Tensor Flow - Developing a greater understanding of the chip and its possibilities

Round Table 3
The Power of Epigenomics- From Age Prediction to Precision Medicine
Jeffrey Bhasin, Director of Informatics, Zymo

Round Table 4
Bayes DB- Understanding systems for implementing AI for the layman
Vikash Mansinghka, Principal Investigator, MIT Probabilistic Computing Project, MIT
Veronica Weiner, CEO and Co-Founder, Resiliance Therapeutics, Director of Special Projects, MIT Probabilistic Computing Project

Round Table 5
AI & Pharmacovigilance- A short introduction

Round Table 6
Sequencing Populations- How to make it effective and fast

Round Table 7
AI in Drug Discovery- Partnering with new AI and tech companies

Round Table 8
Policy and Governance- Update on current legal implications

Round Table 9-
Aging and Drug Development- How investment in aging is becoming an essential topic

Round Table 10-
Policy and Governance

Round Table 11-
Cancer Diagnostics- Liquid biopsies

Round Table 12-
Multimodel Integration- New AI methods
AI & Pharmacovigilance - A short introduction
Anaupam Agarwal, Head, Global Drug Safety and Pharmacovigilance, Zogenix
AI in Drug Discovery- Partnering with new AI and tech companies
Augmenting Human Intelligence through AI
Bayes DB- Understanding systems for implementing AI for the layman
Veronica Weiner, CEO and Co-Founder, Resiliance Therapeutics
Quantum Computing - A short course introduction to the possibilities
The Power of Epigenomics- From Age Prediction to Precision Medicine
Jeffrey Bhasin, Director of Informatics, Zymo Research
last published: 15/Feb/18 18:00 GMT

 

For speaking opportunities, contact
Edward Glanville  at +1 646.619.1773 or
edward.glanville@terrapinn.com